Health Canada has approved an amendment to Optimi Health’s (OTCQX: OPTHF) dealer's license, effectively allowing the company to supply MDMA and psilocybin drugs to the country’s Special Access Program (SAP.)
Alabama's cannabis regulators are scheduled to convene with potential producers and distributors of medical marijuana to resolve the ongoing litigation concerning the state's faulty license allocation process,
In a decisive move to amplify its foothold in the cannabis beverage market, Blaze Life Holdings (BLH) has named Anheuser-Busch InBev SA/NV (NYSE: BUD) veteran, Shreyas Balakrishnan as its new CEO.
Specialty clinical-stage biopharma company SciSparc Ltd. (NASDAQ: SPRC) has received a Nasdaq notice granting the company an additional 180-day compliance period until March 4 to regain compliance with the stock market’s minimum bid price rule.
New York lawmakers will hold a fact-finding hearing next month to address the state’s beleaguered and severely delayed rollout of its legal cannabis industry, state Sen. Jeremy Cooney (D-Rochester) announced Thursday.